79Y-30691-51164
2 vaccinations
6 coded responses
8 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 982 / WA
- Registered
- 2021-05-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Dose 2 — Pfizer-BioNTech
-
2021-05-14
Registered in v-safe
-
2021-05-14
Survey response — day 14, dose 2MedDRA: Decreased appetite, Flushing, Hot flush, Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Repeated arrythmias (PVCs/PACs), hot and cold flashes without fever. Lack of appetite.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Survey response — day 21, dose 2MedDRA: Arrhythmia, Condition aggravated, Fatigue, Feeling cold, Hot flush, Pre-existing disease — Feeling: Poor · Be unable to workFree text: Severe fatigue, flare of autoimmune disease, ESR of 55, CRP 0.09, rise in auto-antibodies, arrythmia, hot/cold flashes.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-27
-
2021-06-03
Survey response — day 35, dose 2MedDRA: Arrhythmia — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Nighttime cardiac arrhythmias. I am now on a 2 week holter monitor.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-03
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
-
2021-07-29
Survey response — 3 months, dose 2MedDRA: Fatigue, Injection site pain, Neuralgia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Worsening of injection site pain; now with nerve involvement. Still extremely fatigued post second injection.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-29
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-09
-
2021-08-09
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-10-28
Survey response — 6 months, dose 2MedDRA: Herpes zoster — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I have developed a 3-1/2 month course of disseminated shingles that is still ongoing.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-29
- 2021-11-03
-
2021-11-09
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-04-29
Survey response — 12 months, dose 2MedDRA: Blood immunoglobulin G increased, Condition aggravated, Herpes zoster, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: exacerbation of MCAS to cutaneous mastocytosis temperature dysregulation reactivation of EBV with high viral IgG still with post Pfizer #2 chronic shingles with high viral IgG now unexplained macrocytosis in the context of sufficient B12 and folateMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-02
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 4
Free text
Release 8 — day 14, dose 2
Symptoms: Repeated arrythmias (PVCs/PACs), hot and cold flashes without fever. Lack of appetite.
Release 8 — day 21, dose 2
Symptoms: Severe fatigue, flare of autoimmune disease, ESR of 55, CRP 0.09, rise in auto-antibodies, arrythmia, hot/cold flashes.
Release 8 — day 35, dose 2
Symptoms: Nighttime cardiac arrhythmias. I am now on a 2 week holter monitor.
Release 9 — 3 months, dose 2
Symptoms: Worsening of injection site pain; now with nerve involvement. Still extremely fatigued post second injection.
Release 10 — 6 months, dose 2
Symptoms: I have developed a 3-1/2 month course of disseminated shingles that is still ongoing.
Release 11 — 12 months, dose 2
Symptoms: exacerbation of MCAS to cutaneous mastocytosis temperature dysregulation reactivation of EBV with high viral IgG still with post Pfizer #2 chronic shingles with high viral IgG now unexplained macrocytosis in the context of sufficient B12 and folate cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arrhythmia | ✓ | ✓ | ✓ |
| SD | Blood immunoglobulin G increased | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling cold | ✓ | ✓ | ✓ |
| SD | Flushing | ✓ | ✓ | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Hot flush | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | · | ✓ |
| SD | Neuralgia | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release